HEADER CHAPERONE 26-JUN-06 2HG1 TITLE N-DOMAIN OF GRP94 IN COMPLEX WITH THE NOVEL LIGAND N-(2-HYDROXYL)ETHYL TITLE 2 CARBOXYAMIDO ADENOSINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOPLASMIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN OF GRP94 RESIDUES (69-337); COMPND 5 SYNONYM: HEAT SHOCK PROTEIN 90 KDA BETA MEMBER 1, 94 KDA GLUCOSE- COMPND 6 REGULATED PROTEIN, GRP94; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 STRAIN: FAMILIARIS; SOURCE 6 GENE: HSP90B1, TRA1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PGEX-NB-GRP94 KEYWDS GRP94, HSP82, HSP90, HTPG, CHAPERONE, LIGAND, NECA, NPCA, NEACA, KEYWDS 2 NEOCA, ADENOSINE EXPDTA X-RAY DIFFRACTION AUTHOR R.M.IMMORMINO,D.T.GEWIRTH REVDAT 3 30-AUG-23 2HG1 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 2HG1 1 VERSN REVDAT 1 05-JUN-07 2HG1 0 JRNL AUTH R.M.IMMORMINO,D.T.GEWIRTH JRNL TITL N-DOMAIN OF GRP94 IN COMPLEX WITH THE NOVEL LIGAND JRNL TITL 2 N-(2-HYDROXYL)ETHYL CARBOXYAMIDO ADENOSINE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2357106.200 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 23793 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2086 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3682 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE : 0.3200 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 215 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3473 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 167 REMARK 3 SOLVENT ATOMS : 231 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 4.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.86000 REMARK 3 B22 (A**2) : -2.21000 REMARK 3 B33 (A**2) : 6.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.34 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.640 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.370 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.240 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.020 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.950 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 42.23 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : 1PE_PG4_COMBINED.PARAM REMARK 3 PARAMETER FILE 4 : NEOCA_NEW.PARAM REMARK 3 PARAMETER FILE 5 : MO6_XPLOR_PARAM.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : 1PE_PG4_COMBINED.TOP REMARK 3 TOPOLOGY FILE 4 : NEOCA.TOP REMARK 3 TOPOLOGY FILE 5 : MO6_XPLOR_TOP.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HG1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUL-06. REMARK 100 THE DEPOSITION ID IS D_1000038305. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-APR-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : YALE MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23793 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11100 REMARK 200 FOR THE DATA SET : 10.0800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.34400 REMARK 200 FOR SHELL : 4.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 2GQP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 7.6 34% PEG 400 25 MM REMARK 280 MGCL2 1.5UL LIGAND PER 100 PROTEIN FOR FINAL CONC 5MM STOCK REMARK 280 NEACA 437MM IN DMSO , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.59500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.41000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.21500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.41000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.59500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.21500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: EACH PROTOMER IN THE ASYMMETRIC UNIT COMPRISES AN ASSUMED REMARK 300 BIOLOGICAL MOLECULE REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 167 REMARK 465 LYS A 168 REMARK 465 SER A 169 REMARK 465 ASP A 184 REMARK 465 GLY A 185 REMARK 465 THR A 286 REMARK 465 GLY A 287 REMARK 465 GLY A 288 REMARK 465 GLY A 289 REMARK 465 GLY A 290 REMARK 465 LYS A 328 REMARK 465 LYS B 168 REMARK 465 SER B 169 REMARK 465 ASP B 184 REMARK 465 GLY B 185 REMARK 465 THR B 286 REMARK 465 GLY B 287 REMARK 465 GLY B 288 REMARK 465 GLY B 289 REMARK 465 GLY B 290 REMARK 465 LYS B 328 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 TYR A 94 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 GLU A 123 CG CD OE1 OE2 REMARK 470 GLU A 130 CG CD OE1 OE2 REMARK 470 LYS A 140 CG CD CE NZ REMARK 470 GLU A 141 CG CD OE1 OE2 REMARK 470 SER A 172 OG REMARK 470 GLU A 173 CG CD OE1 OE2 REMARK 470 LEU A 175 CG CD1 CD2 REMARK 470 ASN A 176 CG OD1 ND2 REMARK 470 LYS A 177 CG CD CE NZ REMARK 470 GLU A 180 CG CD OE1 OE2 REMARK 470 GLN A 182 CG CD OE1 NE2 REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 GLN A 186 CG CD OE1 NE2 REMARK 470 GLU A 190 CG CD OE1 OE2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 THR A 329 OG1 CG2 REMARK 470 GLU B 71 CG CD OE1 OE2 REMARK 470 LYS B 72 CG CD CE NZ REMARK 470 LYS B 95 CG CD CE NZ REMARK 470 GLU B 123 CG CD OE1 OE2 REMARK 470 GLU B 157 CG CD OE1 OE2 REMARK 470 SER B 172 OG REMARK 470 GLU B 173 CG CD OE1 OE2 REMARK 470 LEU B 175 CG CD1 CD2 REMARK 470 LYS B 177 CG CD CE NZ REMARK 470 GLU B 180 CG CD OE1 OE2 REMARK 470 GLN B 182 CG CD OE1 NE2 REMARK 470 GLU B 183 CG CD OE1 OE2 REMARK 470 GLN B 186 CG CD OE1 NE2 REMARK 470 GLU B 190 CG CD OE1 OE2 REMARK 470 LYS B 285 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 129 105.32 -179.91 REMARK 500 THR A 150 43.90 -108.41 REMARK 500 SER A 227 -9.60 87.55 REMARK 500 GLU A 229 175.37 170.53 REMARK 500 ARG A 243 138.11 -171.91 REMARK 500 ASN B 129 105.11 -173.31 REMARK 500 SER B 227 -13.03 91.34 REMARK 500 GLU B 229 -179.18 177.70 REMARK 500 ARG B 243 133.64 -170.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH B 703 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 701 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B 702 O REMARK 620 2 HOH B 703 O 178.3 REMARK 620 3 HOH B 704 O 89.0 89.6 REMARK 620 4 HOH B 705 O 87.7 93.7 176.4 REMARK 620 5 HOH B 706 O 91.4 89.5 87.9 90.7 REMARK 620 6 HOH B 707 O 92.1 86.8 84.9 96.7 171.9 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE N5O A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE N5O B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1PE B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1U0Y RELATED DB: PDB REMARK 900 N-DOMAIN OF GRP94, LACKING THE CHARGED DOMAIN, IN COMPLEX WITH THE REMARK 900 NOVEL LIGAND N-PROPYL CARBOXYAMIDO ADENOSINE REMARK 900 RELATED ID: 1U2O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE N-DOMAIN OF GRP94 LACKING THE CHARGED REMARK 900 DOMAIN IN COMPLEX WITH NECA REMARK 900 RELATED ID: 1YT1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94, THE ER HSP90: REMARK 900 BASIS FOR NUCLEOTIDE-INDUCED CONFORMATIONAL CHANGE, GRP94N(DELTA)41 REMARK 900 APO CRYSTAL REMARK 900 RELATED ID: 2GQP RELATED DB: PDB REMARK 900 N-DOMAIN OF GRP94 IN COMPLEX WITH THE NOVEL LIGAND N-PROPYL REMARK 900 CARBOXYAMIDO ADENOSINE REMARK 900 RELATED ID: 2HCH RELATED DB: PDB REMARK 900 N-DOMAIN OF GRP94 IN COMPLEX WITH THE NOVEL LIGAND N-(2-AMINO)ETHYL REMARK 900 CARBOXYAMIDO ADENOSINE REMARK 900 RELATED ID: 2H8M RELATED DB: PDB REMARK 900 N-DOMAIN OF GRP94 IN COMPLEX WITH THE 2-IODO-NECA REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE DATABASE RESIDUES 287-327 WERE DELETED REMARK 999 AND REPLACED BY 4 GLYCINES. DBREF 2HG1 A 69 286 UNP P41148 ENPL_CANFA 69 286 DBREF 2HG1 B 69 286 UNP P41148 ENPL_CANFA 69 286 SEQADV 2HG1 GLY A 65 UNP P41148 EXPRESSION TAG SEQADV 2HG1 SER A 66 UNP P41148 EXPRESSION TAG SEQADV 2HG1 HIS A 67 UNP P41148 EXPRESSION TAG SEQADV 2HG1 MET A 68 UNP P41148 EXPRESSION TAG SEQADV 2HG1 GLY A 287 UNP P41148 SEE REMARK 999 SEQADV 2HG1 GLY A 288 UNP P41148 SEE REMARK 999 SEQADV 2HG1 GLY A 289 UNP P41148 SEE REMARK 999 SEQADV 2HG1 GLY A 290 UNP P41148 SEE REMARK 999 SEQADV 2HG1 GLY B 65 UNP P41148 EXPRESSION TAG SEQADV 2HG1 SER B 66 UNP P41148 EXPRESSION TAG SEQADV 2HG1 HIS B 67 UNP P41148 EXPRESSION TAG SEQADV 2HG1 MET B 68 UNP P41148 EXPRESSION TAG SEQADV 2HG1 GLY B 287 UNP P41148 SEE REMARK 999 SEQADV 2HG1 GLY B 288 UNP P41148 SEE REMARK 999 SEQADV 2HG1 GLY B 289 UNP P41148 SEE REMARK 999 SEQADV 2HG1 GLY B 290 UNP P41148 SEE REMARK 999 SEQRES 1 A 236 GLY SER HIS MET LEU ARG GLU LYS SER GLU LYS PHE ALA SEQRES 2 A 236 PHE GLN ALA GLU VAL ASN ARG MET MET LYS LEU ILE ILE SEQRES 3 A 236 ASN SER LEU TYR LYS ASN LYS GLU ILE PHE LEU ARG GLU SEQRES 4 A 236 LEU ILE SER ASN ALA SER ASP ALA LEU ASP LYS ILE ARG SEQRES 5 A 236 LEU ILE SER LEU THR ASP GLU ASN ALA LEU ALA GLY ASN SEQRES 6 A 236 GLU GLU LEU THR VAL LYS ILE LYS CYS ASP LYS GLU LYS SEQRES 7 A 236 ASN LEU LEU HIS VAL THR ASP THR GLY VAL GLY MET THR SEQRES 8 A 236 ARG GLU GLU LEU VAL LYS ASN LEU GLY THR ILE ALA LYS SEQRES 9 A 236 SER GLY THR SER GLU PHE LEU ASN LYS MET THR GLU ALA SEQRES 10 A 236 GLN GLU ASP GLY GLN SER THR SER GLU LEU ILE GLY GLN SEQRES 11 A 236 PHE GLY VAL GLY PHE TYR SER ALA PHE LEU VAL ALA ASP SEQRES 12 A 236 LYS VAL ILE VAL THR SER LYS HIS ASN ASN ASP THR GLN SEQRES 13 A 236 HIS ILE TRP GLU SER ASP SER ASN GLU PHE SER VAL ILE SEQRES 14 A 236 ALA ASP PRO ARG GLY ASN THR LEU GLY ARG GLY THR THR SEQRES 15 A 236 ILE THR LEU VAL LEU LYS GLU GLU ALA SER ASP TYR LEU SEQRES 16 A 236 GLU LEU ASP THR ILE LYS ASN LEU VAL LYS LYS TYR SER SEQRES 17 A 236 GLN PHE ILE ASN PHE PRO ILE TYR VAL TRP SER SER LYS SEQRES 18 A 236 THR GLY GLY GLY GLY LYS THR VAL TRP ASP TRP GLU LEU SEQRES 19 A 236 MET ASN SEQRES 1 B 236 GLY SER HIS MET LEU ARG GLU LYS SER GLU LYS PHE ALA SEQRES 2 B 236 PHE GLN ALA GLU VAL ASN ARG MET MET LYS LEU ILE ILE SEQRES 3 B 236 ASN SER LEU TYR LYS ASN LYS GLU ILE PHE LEU ARG GLU SEQRES 4 B 236 LEU ILE SER ASN ALA SER ASP ALA LEU ASP LYS ILE ARG SEQRES 5 B 236 LEU ILE SER LEU THR ASP GLU ASN ALA LEU ALA GLY ASN SEQRES 6 B 236 GLU GLU LEU THR VAL LYS ILE LYS CYS ASP LYS GLU LYS SEQRES 7 B 236 ASN LEU LEU HIS VAL THR ASP THR GLY VAL GLY MET THR SEQRES 8 B 236 ARG GLU GLU LEU VAL LYS ASN LEU GLY THR ILE ALA LYS SEQRES 9 B 236 SER GLY THR SER GLU PHE LEU ASN LYS MET THR GLU ALA SEQRES 10 B 236 GLN GLU ASP GLY GLN SER THR SER GLU LEU ILE GLY GLN SEQRES 11 B 236 PHE GLY VAL GLY PHE TYR SER ALA PHE LEU VAL ALA ASP SEQRES 12 B 236 LYS VAL ILE VAL THR SER LYS HIS ASN ASN ASP THR GLN SEQRES 13 B 236 HIS ILE TRP GLU SER ASP SER ASN GLU PHE SER VAL ILE SEQRES 14 B 236 ALA ASP PRO ARG GLY ASN THR LEU GLY ARG GLY THR THR SEQRES 15 B 236 ILE THR LEU VAL LEU LYS GLU GLU ALA SER ASP TYR LEU SEQRES 16 B 236 GLU LEU ASP THR ILE LYS ASN LEU VAL LYS LYS TYR SER SEQRES 17 B 236 GLN PHE ILE ASN PHE PRO ILE TYR VAL TRP SER SER LYS SEQRES 18 B 236 THR GLY GLY GLY GLY LYS THR VAL TRP ASP TRP GLU LEU SEQRES 19 B 236 MET ASN HET N5O A 401 23 HET PG4 A 501 13 HET PG4 A 502 13 HET PG4 A 505 13 HET PG4 A 508 13 HET MG B 701 1 HET N5O B 402 23 HET PG4 B 503 13 HET PG4 B 504 13 HET PG4 B 506 13 HET PG4 B 507 13 HET 1PE B 601 16 HETNAM N5O 5'-N-(2-HYDROXYL)ETHYL CARBOXYAMIDO ADENOSINE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM MG MAGNESIUM ION HETNAM 1PE PENTAETHYLENE GLYCOL HETSYN N5O (2S,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXY- HETSYN 2 N5O N-(2-HYDROXYETHYL)TETRAHYDROFURAN-2-CARBOXAMIDE HETSYN 1PE PEG400 FORMUL 3 N5O 2(C12 H16 N6 O5) FORMUL 4 PG4 8(C8 H18 O5) FORMUL 8 MG MG 2+ FORMUL 14 1PE C10 H22 O6 FORMUL 15 HOH *231(H2 O) HELIX 1 1 SER A 66 GLU A 71 1 6 HELIX 2 2 GLN A 79 LEU A 93 1 15 HELIX 3 3 TYR A 94 LYS A 97 5 4 HELIX 4 4 GLU A 98 ASP A 122 1 25 HELIX 5 5 THR A 155 THR A 165 1 11 HELIX 6 6 GLY A 170 ALA A 181 1 12 HELIX 7 7 THR A 188 GLY A 196 1 9 HELIX 8 8 VAL A 197 LEU A 204 5 8 HELIX 9 9 GLU A 253 LEU A 259 5 7 HELIX 10 10 GLU A 260 GLN A 273 1 14 HELIX 11 11 SER B 66 GLU B 71 1 6 HELIX 12 12 GLN B 79 LEU B 93 1 15 HELIX 13 13 GLU B 98 ASP B 122 1 25 HELIX 14 14 LYS B 140 LYS B 142 5 3 HELIX 15 15 THR B 155 THR B 165 1 11 HELIX 16 16 GLY B 170 GLU B 183 1 14 HELIX 17 17 THR B 188 PHE B 195 1 8 HELIX 18 18 VAL B 197 LEU B 204 5 8 HELIX 19 19 GLU B 253 LEU B 259 5 7 HELIX 20 20 GLU B 260 SER B 272 1 13 SHEET 1 A 9 LYS A 75 PHE A 76 0 SHEET 2 A 9 PHE A 230 ALA A 234 -1 O PHE A 230 N PHE A 76 SHEET 3 A 9 HIS A 221 SER A 225 -1 N ILE A 222 O ILE A 233 SHEET 4 A 9 ALA A 206 LYS A 214 -1 N VAL A 211 O TRP A 223 SHEET 5 A 9 GLY A 244 LEU A 251 -1 O THR A 248 N ILE A 210 SHEET 6 A 9 LEU A 144 ASP A 149 -1 N LEU A 145 O LEU A 249 SHEET 7 A 9 VAL A 134 ASP A 139 -1 N LYS A 135 O THR A 148 SHEET 8 A 9 ILE A 279 SER A 284 1 O TYR A 280 N ILE A 136 SHEET 9 A 9 TRP A 331 LEU A 335 -1 O ASP A 332 N SER A 283 SHEET 1 B 9 LYS B 75 PHE B 76 0 SHEET 2 B 9 PHE B 230 ALA B 234 -1 O PHE B 230 N PHE B 76 SHEET 3 B 9 HIS B 221 SER B 225 -1 N ILE B 222 O ILE B 233 SHEET 4 B 9 ALA B 206 LYS B 214 -1 N VAL B 211 O TRP B 223 SHEET 5 B 9 GLY B 244 LEU B 251 -1 O THR B 248 N ILE B 210 SHEET 6 B 9 LEU B 144 ASP B 149 -1 N ASP B 149 O THR B 245 SHEET 7 B 9 VAL B 134 ASP B 139 -1 N LYS B 135 O THR B 148 SHEET 8 B 9 ILE B 279 SER B 284 1 O TYR B 280 N ILE B 136 SHEET 9 B 9 TRP B 331 LEU B 335 -1 O ASP B 332 N SER B 283 LINK MG MG B 701 O HOH B 702 1555 1555 2.04 LINK MG MG B 701 O HOH B 703 1555 1555 1.97 LINK MG MG B 701 O HOH B 704 1555 1555 2.09 LINK MG MG B 701 O HOH B 705 1555 1555 2.07 LINK MG MG B 701 O HOH B 706 1555 1555 2.14 LINK MG MG B 701 O HOH B 707 1555 1555 2.12 SITE 1 AC1 18 ASN A 107 ALA A 111 ASP A 149 MET A 154 SITE 2 AC1 18 ASN A 162 LEU A 163 GLY A 196 VAL A 197 SITE 3 AC1 18 TYR A 200 THR A 245 HOH A 510 HOH A 521 SITE 4 AC1 18 HOH A 529 HOH A 538 HOH A 549 HOH A 550 SITE 5 AC1 18 HOH A 552 HOH A 559 SITE 1 AC2 10 THR A 212 ARG A 237 THR A 240 THR A 246 SITE 2 AC2 10 THR A 248 PG4 A 502 HOH A 512 HOH A 513 SITE 3 AC2 10 HOH A 514 HOH A 551 SITE 1 AC3 6 LYS A 137 HIS A 146 TRP A 282 PG4 A 501 SITE 2 AC3 6 HOH A 517 HOH A 530 SITE 1 AC4 5 ASP A 110 LYS A 114 LEU A 117 HOH A 598 SITE 2 AC4 5 HOH A 611 SITE 1 AC5 6 LYS A 75 PHE A 76 ALA A 77 HOH A 515 SITE 2 AC5 6 HOH A 620 HOH B 811 SITE 1 AC6 6 ASP B 218 HOH B 702 HOH B 704 HOH B 705 SITE 2 AC6 6 HOH B 706 HOH B 707 SITE 1 AC7 18 ALA B 111 ASP B 149 MET B 154 ASN B 162 SITE 2 AC7 18 LEU B 163 GLY B 196 PHE B 199 TYR B 200 SITE 3 AC7 18 THR B 245 HOH B 710 HOH B 735 HOH B 740 SITE 4 AC7 18 HOH B 749 HOH B 755 HOH B 762 HOH B 764 SITE 5 AC7 18 HOH B 766 HOH B 809 SITE 1 AC8 8 THR B 212 ARG B 237 THR B 240 THR B 246 SITE 2 AC8 8 THR B 248 HOH B 708 HOH B 747 HOH B 801 SITE 1 AC9 4 LYS B 137 TRP B 282 HOH B 773 HOH B 803 SITE 1 BC1 3 GLU B 130 ASN B 239 GLY B 242 SITE 1 BC2 5 ASP B 262 THR B 263 ASN B 266 HOH B 720 SITE 2 BC2 5 HOH B 805 SITE 1 BC3 11 ASN A 83 MET A 86 LYS A 87 ILE A 90 SITE 2 BC3 11 SER A 227 ASN B 83 LYS B 87 ILE B 90 SITE 3 BC3 11 SER B 227 HOH B 715 HOH B 741 CRYST1 65.190 84.430 94.820 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015340 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011844 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010546 0.00000